Based on the Cox multivariate regression analysis of NLRP3 in our risk model, we posited that NLRP3 might act as a potential predictor of HNSCC patient outcomes (HR = 0.68, P = 0.039). This evidence concerns the gene NLRP3 and head and neck squamous cell carcinoma.